Assessment of Ultra-Early Administration of Sacubitril Valsartan to Improve Cardiac Remodeling in Patients With Acute Myocardial Infarction Following Primary PCI: Rational and Design of a Prospective, Multicenter, Randomized Controlled Trial

Despite coronary re-vascularization, the common complications of acute myocardial infarction (AMI), cardiac remodeling, and heart failure (HF), is increasing globally. Sacubitril valsartan (SV), an angiotensin receptor-neprilysin inhibitor (ARNI), has been previously demonstrated to improve HF. We f...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in physiology Vol. 13; p. 831212
Main Authors Li, Zhengwei, Fu, Guosheng
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 10.02.2022
Subjects
Online AccessGet full text

Cover

Loading…